Back to All Events

Science Board to FDA

The Science Board heard a report from the Center for Biologics Evaluation and Research Program Review Subcommittee; heard about FDA’s Patient Affairs Initiative; and discussed how the Agency can leverage its existing tools and authorities, and work with stakeholders, to better address the complex scientific, public health, and technology challenges it faces today.